基于磁热过热的向治疗癌症治疗的进展
Neha Srivastava1, Bhupendra Chudasama2, Manoj Baranwal1
1Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, India.
Biointerphases
|December 11, 2023
概括
使用磁纳米粒子 (MNP) 进行磁性高温疗法提供了一个有前途的癌症治疗方法. 积极准癌症生物标志物可以增强MNP的传递,在与其他疗法相结合时提高治疗疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 使用磁纳米颗粒 (MNP) 和交替磁场 (AMF) 的磁性高热 (MH) 是一种正在发展中的癌症疗法.
- 积极向策略提高了MNP向癌细胞传递的特异性和有效性.
- 癌细胞表达出独特的生物标志物,这些生物标志物可以被MNP准.
研究的目的:
- 审查癌症特异性生物标志物,以积极准MNP.
- 探索磁热高温与其他癌症治疗的协同效应.
- 提供针对癌症治疗的有针对性的磁性高温症当前进展的概述.
主要方法:
- 关于癌症生物标志物的文献审查及其在积极向中的作用.
- 分析MNP-连接物相互作用,以实现有针对性的交付.
- 检查涉及磁热过热的组合疗法.
主要成果:
- 确定了关键的癌症生物标志物,包括生长因子,受体 (例如EGFR,转激素,叶酸,CXCR4) 和集群分化 (CD) 标志物 (例如CD44,CD133).
- 证明MNP上的配体可以与这些生物标志物结合,以精确地向癌细胞.
- 当磁性高温症与化疗,辐射,基因和免疫疗法相结合时,突出突出协同效应.
结论:
- 用MNP对癌症生物标志物的积极向提高了磁性高温疗效.
- 组合疗法显著改善了整体癌症治疗结果.
- 向性磁热过热代表了瘤学中的多功能和有前途的战略.
更多相关视频
06:45In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
Published on: July 2, 2020
4.3K
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.4K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K
